Merck & Co. to Invest $90M to Set Up New Translational Med Center in San Diego – Genetic Engineering News
By Dr. Matthew Watson
 Nature.com | Merck & Co. to Invest $90M to Set Up New Translational Med Center in San Diego Genetic Engineering News Merck & Co. will join with a chemist-turned-biotechnology entrepreneur to launch the California Institute for Biomedical Research (Calibr) in La Jolla, CA, with the goal of advancing discoveries into new drugs. Merck will provide the new nonprofit ... Merck Partners with Academic Scientists and Biotechnology Entrepreneurs to ...MarketWatch (press release) Deals and Moves: March 16NJBIZ Merck collaboration will create non-profit drug research instituteThe Star-Ledger - NJ.com |
Source:
http://news.google.com/news?q=biotechnology&output=rss
Uncategorized
Comments Off on Merck & Co. to Invest $90M to Set Up New Translational Med Center in San Diego – Genetic Engineering News |
March 18th, 2012
This author published 5872 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research